- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00876005
Supplemental Oxygen and the Risk of Surgical Site Infection (PORSSI)
October 12, 2016 updated by: Santa Clara Valley Health & Hospital System
Perioperative Supplemental Oxygen and the Risk of Surgical Site Infection
This is a study to see whether increasing the oxygen concentration during and after a cesarean section decreases the infection rate.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a double-blinded prospective randomized,controlled trial to evaluate whether using a higher concentration of oxygen during and after surgery helps to decrease the wound infection rate in patients undergoing cesarean sections.
Study Type
Interventional
Enrollment (Anticipated)
1202
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Jose, California, United States, 95128
- Santa Clara Valley Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- mentally competent patients undergoing cesarean section under spinal or epidural anesthesia
Exclusion Criteria:
- fever/chorioamnionitis; GBS positive on antibiotics; immunocompromised / HIV patients; on antibiotics for any reason; general anesthesia; age less than 18 years custody patients stat cesarean section
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1
80% oxygen during cesarean section
|
Postoperatively, an aerosol face mask is used to deliver oxygen at 80%
Other Names:
Postoperatively, an aerosol face mask is used to deliver oxygen at 30%
Other Names:
|
Active Comparator: 2
30% oxygen during cesarean section
|
Postoperatively, an aerosol face mask is used to deliver oxygen at 80%
Other Names:
Postoperatively, an aerosol face mask is used to deliver oxygen at 30%
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Surgical site infection
Time Frame: 2 weeks
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Neena Duggal, MD, Santa Clara Valley Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2006
Primary Completion (Actual)
April 1, 2011
Study Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
April 3, 2009
First Submitted That Met QC Criteria
April 3, 2009
First Posted (Estimate)
April 6, 2009
Study Record Updates
Last Update Posted (Estimate)
October 13, 2016
Last Update Submitted That Met QC Criteria
October 12, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5/11/07-04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Site Infection
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemCompletedSurgical Site Infection | Superficial Surgical Site Infection | Deep Surgical Site Infection | Organ/Space Surgical Site InfectionUnited States
-
Region SkaneVinnovaCompleted
-
MinaPharm PharmaceuticalsRecruitingSurgical Site InfectionsEgypt
-
Karolinska University HospitalStockholm South General HospitalRecruitingPostoperative Surgical Site InfectionSweden
-
Washington University School of MedicineCompleted
-
Singapore General HospitalNovem Healthcare Pte LtdTerminatedSuperficial Surgical Site InfectionSingapore
-
Halmstad County HospitalCompleted
-
Population Health Research InstituteActive, not recruitingSurgical Site InfectionsCanada
-
University of RochesterSage Products, Inc.Completed
-
Montefiore Medical CenterCompletedSurgical Site Infection Following Cesarean DeliveryUnited States
Clinical Trials on Oxygen by mask
-
Washington University School of MedicineCompletedFetal Hypoxia | Electronic Fetal Monitoring | Fetal-Placental CirculationUnited States
-
Mahidol UniversityCompleted
-
Region SkaneCompleted
-
Nantes University HospitalCompletedSevere Obesity Design as BMI > 35kg/m2France
-
Western University, CanadaCompletedPulmonary Atelectasis | Patient ComfortCanada
-
Alexandria UniversityCompletedPost Operative Pulmonary ComplicationsEgypt
-
Cliniques universitaires Saint-Luc- Université...CompletedCovid19 | HypoxemiaBelgium
-
University of ZurichCompletedPulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension | Chronic Cardiorespiratory DiseaseSwitzerland
-
Emory UniversityCompletedRapid Sequence IntubationUnited States